HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Keijiro Saku Selected Research

Cardiac Rehabilitation

11/2022Study Design of the Japanese Association of Cardiac Rehabilitation Registry (J-CARRY)　- Protocol for a Prospective, Multicenter, Open Registry.
11/2020Effects of Phase II Comprehensive Cardiac Rehabilitation on Risk Factor Modification and Exercise Capacity in Patients With Acute Coronary Syndrome　- Results From the JACR Registry.
12/2017Cardiac rehabilitation in patients with cardiovascular disease leads various hemodynamic parameters obtained using simple non-invasive tests to their appropriate levels.
4/2017Significance of Cardiac Rehabilitation on Visit-to-Visit Variability of Blood Pressure in Patients With Cardiovascular Disease in a 12-Month Follow-Up.
9/2016Visit-to-Visit Variability and Reduction in Blood Pressure After a 3-Month Cardiac Rehabilitation Program in Patients With Cardiovascular Disease.
9/2016Assessment of various parameters using simple non-invasive tests in patients with cardiovascular diseases with or without cardiac rehabilitation.
10/2015Influence of a Cardiac Rehabilitation Program on Renal Function in Patients With Cardiovascular Disease in a One-Year Follow-Up.
12/2014Effects of treatment with a combination of cardiac rehabilitation and bosentan in patients with pulmonary Langerhans cell histiocytosis associated with pulmonary hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Keijiro Saku Research Topics

Disease

37Coronary Artery Disease (Coronary Atherosclerosis)
01/2019 - 11/2002
33Hypertension (High Blood Pressure)
01/2023 - 09/2003
27Cardiovascular Diseases (Cardiovascular Disease)
11/2022 - 07/2006
26Myocardial Infarction
10/2021 - 01/2003
21Atherosclerosis
01/2018 - 09/2002
15Atrial Fibrillation
01/2018 - 07/2002
15Pathologic Constriction (Stenosis)
01/2017 - 10/2003
14Heart Failure
01/2021 - 12/2003
10Stable Angina
02/2018 - 01/2008
10Inflammation (Inflammations)
08/2016 - 04/2004
9Diabetes Mellitus
08/2016 - 07/2006
8Acute Coronary Syndrome
11/2020 - 01/2005
8Essential Hypertension
01/2020 - 03/2003
8Coronary Restenosis
08/2016 - 10/2003
7Thrombosis (Thrombus)
03/2017 - 01/2009
7Coronary Stenosis (Coronary Artery Stenosis)
01/2016 - 10/2003
7Hypercholesterolemia
01/2012 - 01/2005
6Type 2 Diabetes Mellitus (MODY)
01/2023 - 10/2005
6Stroke (Strokes)
10/2021 - 12/2016
6Hypertriglyceridemia
12/2020 - 12/2004
6Coronary Disease (Coronary Heart Disease)
01/2012 - 12/2003
5Atherosclerotic Plaque (Atheroma)
01/2017 - 10/2007
5Neoplasms (Cancer)
01/2017 - 01/2004
5Hyperlipidemias (Hyperlipidemia)
03/2011 - 01/2005
5Cardiomegaly (Heart Hypertrophy)
10/2009 - 01/2003
4Body Weight (Weight, Body)
05/2017 - 09/2002
4Ischemia
03/2016 - 04/2007
3ST Elevation Myocardial Infarction
01/2023 - 11/2020
3Non-ST Elevated Myocardial Infarction
10/2021 - 09/2020
3Fibrosis (Cirrhosis)
07/2019 - 06/2003
3Reperfusion Injury
10/2016 - 02/2010
3Myocardial Ischemia (Ischemic Heart Diseases)
10/2016 - 04/2007
3Left Ventricular Dysfunction
01/2009 - 07/2005
3Dyslipidemias (Dyslipidemia)
08/2008 - 01/2008
2Chronic Renal Insufficiency
01/2021 - 03/2011
2Unstable Angina
01/2021 - 01/2019
2Cardiac Arrhythmias (Arrythmia)
11/2020 - 04/2008

Drug/Important Bio-Agent (IBA)

23CholesterolIBA
01/2023 - 09/2002
22LipidsIBA
01/2023 - 09/2002
21Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2021 - 02/2004
20oxidized low density lipoproteinIBA
11/2019 - 04/2004
16Angiotensin IIIBA
05/2017 - 01/2003
12HDL LipoproteinsIBA
01/2023 - 05/2003
12Angiotensin II Type 1 Receptor BlockersIBA
01/2020 - 06/2003
12LDL CholesterolIBA
11/2019 - 09/2002
10Valsartan (Vals)FDA Link
01/2016 - 09/2003
9Chymases (Chymase)IBA
06/2018 - 09/2002
9HDL CholesterolIBA
01/2018 - 04/2004
9Apolipoprotein A-I (Apolipoprotein A1)IBA
03/2016 - 02/2004
8olmesartanIBA
05/2017 - 07/2009
8Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
05/2017 - 06/2003
8Lipoproteins (Lipoprotein)IBA
05/2010 - 08/2004
7omega-Chloroacetophenone (Mace)IBA
10/2021 - 01/2011
7ApolipoproteinsIBA
12/2020 - 08/2004
7Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2020 - 02/2004
7Angiotensin Receptor AntagonistsIBA
05/2017 - 03/2003
7Losartan (Cozaar)FDA LinkGeneric
12/2015 - 01/2007
7AdiponectinIBA
11/2015 - 08/2008
6LDL Lipoproteins (beta Lipoproteins)IBA
02/2019 - 04/2004
6Hydrochlorothiazide (Esidrix)FDA LinkGeneric
02/2017 - 01/2008
6Atorvastatin (Lipitor)FDA Link
08/2012 - 04/2004
5Triglycerides (Triacylglycerol)IBA
01/2023 - 11/2006
5Proteins (Proteins, Gene)FDA Link
11/2020 - 10/2003
5RivaroxabanIBA
01/2018 - 10/2016
5Antihypertensive Agents (Antihypertensives)IBA
12/2016 - 11/2004
5Peptides (Polypeptides)IBA
03/2016 - 04/2010
5Pravastatin (Pravachol)FDA LinkGeneric
12/2008 - 11/2002
4Amlodipine (Norvasc)FDA LinkGeneric
04/2019 - 10/2015
4SaltsIBA
06/2018 - 01/2010
4AnticoagulantsIBA
03/2017 - 01/2009
4MetalsIBA
08/2016 - 01/2008
4IrbesartanFDA LinkGeneric
01/2016 - 01/2012
4C-Reactive ProteinIBA
11/2015 - 01/2006
3azilsartanIBA
05/2017 - 01/2013
3EnzymesIBA
05/2017 - 10/2003
3Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2016 - 04/2008
3Uric Acid (Urate)IBA
01/2016 - 01/2007
3Rosuvastatin Calcium (Crestor)FDA Link
10/2014 - 09/2009
3candesartanIBA
02/2013 - 06/2003
3Ezetimibe (Zetia)FDA Link
08/2012 - 01/2008
3low density lipoprotein inhibitorIBA
01/2012 - 12/2005
3ChemokinesIBA
01/2008 - 10/2003
3Chemokine ReceptorsIBA
01/2008 - 10/2003
3pilsicainideIBA
01/2006 - 12/2004
2Lipase (Acid Lipase)FDA Link
12/2020 - 11/2020
2Lipoprotein Lipase (Diacylglycerol Lipase)IBA
12/2020 - 12/2004
2Apolipoproteins E (ApoE)IBA
12/2020 - 09/2006
2Brain Natriuretic Peptide (Natrecor)FDA Link
09/2020 - 03/2012

Therapy/Procedure

35Therapeutics
01/2021 - 03/2003
18Stents
02/2018 - 01/2005
14Percutaneous Coronary Intervention
01/2023 - 01/2009
8Cardiac Rehabilitation
11/2022 - 12/2014
6Secondary Prevention
10/2021 - 08/2008
4Catheter Ablation
06/2020 - 07/2002
4Renal Dialysis (Hemodialysis)
02/2018 - 01/2004
4Aftercare (After-Treatment)
05/2017 - 04/2012
4Catheters
01/2016 - 07/2002
3Drug-Eluting Stents
01/2017 - 02/2013
3Glycemic Control
05/2015 - 10/2005
3Coronary Artery Bypass (Coronary Artery Bypass Surgery)
04/2012 - 02/2007